5:30 PM
Feb 15, 2013
 |  BC Extra  |  Financial News

AbbVie unveils $1.5B buyback program

AbbVie Inc. (NYSE:ABBV) said its board authorized the repurchase of up to $1.5 billion of...

Read the full 58 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >